Submitted by Anonymous (not verified) on 25 September 2025 - 16:57
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Date of authorisation: 13/12/2024, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Alhemo, concizumab, Date of authorisation: 13/12/2024, Revision: 1, Status: Authorised